Trials / Sponsors / US Oncology Research
US Oncology Research
Industry · 29 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | MYLUNG Consortium Part 3: Observational Study Carcinoma, Non-Small-Cell Lung | — | 2023-01-30 |
| Active Not Recruiting | Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma Multiple Myeloma, Myeloma Multiple, Kahler Disease | Phase 2 | 2021-09-10 |
| Active Not Recruiting | MYLUNG Consortium Study Protocol 2 Carcinoma, Non-Small-Cell Lung | — | 2020-12-29 |
| Active Not Recruiting | Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer Breast Neoplasms, Malignant Neoplasm of Breast | Phase 1 / Phase 2 | 2017-11-29 |
| Terminated | Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) Af Colorectal Neoplasms, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 2 | 2015-03-26 |
| Completed | Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Canc Breast Cancer, Breast Carcinoma, Breast Tumors | Phase 2 | 2015-02-12 |
| Terminated | Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Neoplasms, Malignant Tumor of the Breast | Phase 2 | 2014-12-01 |
| Completed | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus Stomatitis, Oral Mucositis, Neoplasm of the Breast | Phase 2 | 2014-09-04 |
| Completed | STAR Cape+BKM120 MBC With Brain Met Brain Metastases, Breast Cancer, Metastatic Breast Cancer | Phase 2 | 2014-05-29 |
| Unknown | Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 1 | 2014-03-01 |
| Completed | Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC) Colorectal Neoplasms, Advanced Metastatic Colorectal Cancer | — | 2013-07-01 |
| Completed | Synera Venipuncture Pain Pain, Phlebotomy, Palliative Care | Phase 2 | 2013-01-01 |
| Completed | Triple Negative Breast Cancer Biomarker Study Metastatic Breast Cancer, Triple Negative Breast Cancer | — | 2010-05-01 |
| Completed | Ixabepilone + Carboplatin Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2010-01-01 |
| Completed | Sunitinib Non Small Cell Lung Cancer Patients Over 70 Non Small Cell Lung Cancer | Phase 2 | 2009-02-01 |
| Completed | Gemzar, Cisp, Sunitinib Urothelial Ca Urothelial Cancer | Phase 2 | 2008-08-01 |
| Completed | Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) Androgen-independent Prostate Cancer | Phase 2 | 2008-05-01 |
| Completed | Docetaxel+Oxali+/-Cetux Met Gastric/GEJ Gastric Cancer Adenocarcinoma Metastatic | Phase 2 | 2007-07-01 |
| Completed | Adj TC + Herceptin Early Stage Breast Cancer Breast Cancer | Phase 2 | 2007-06-01 |
| Completed | TAC Versus TC for Adjuvant Breast Cancer Breast Cancer | Phase 3 | 2007-05-29 |
| Completed | Phase II Sunitinib Prog Met AIPC Metastatic Prostate Cancer | Phase 2 | 2007-03-01 |
| Completed | Pre-op Rectal ChemoRad +/- Cetuximab Rectal Cancer | Phase 2 | 2007-02-01 |
| Completed | Vidaza to Restore Hormone Thx Prostate Prostate Cancer | Phase 2 | 2006-04-01 |
| Completed | Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2005-12-01 |
| Terminated | Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Non-Hodgkin's Lymphoma | Phase 2 | 2005-10-01 |
| Completed | Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Metastatic Colorectal Cancer | Phase 3 | 2005-09-01 |
| Active Not Recruiting | PhII ICb With/Without Erbitux in MBC Pts Metastatic Breast Cancer | Phase 2 | 2005-07-28 |
| Completed | Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell Relapsed or Refractory Mantle Cell Lymphoma (MCL) | Phase 2 | 2004-12-01 |
| Completed | Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously B-Cell Chronic Lymphocytic Leukemia | Phase 3 | 2003-12-01 |